HOOKIPA Pharma Inc (HOOK) FinancialsHOOKHOOKIPA Pharma Inc

Evaluating the bottom line, HOOKIPA Pharma Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -873.95%, while the net margin is -769.81%. These profitability ratios, combined with a Return on Equity (ROE) of -105.79%, provide a clear picture of how effectively HOOK converts its operational activities into shareholder value.

In the context of the broader market, HOOK competes directly with industry leaders such as PHIO and EVGN. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, HOOK's gross margin of 100.00% stands against PHIO's N/A and EVGN's 40.63%. Such benchmarking helps identify whether HOOKIPA Pharma Inc is trading at a premium or discount relative to its financial performance.